Patents by Inventor Rachael Dunlop

Rachael Dunlop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
    Patent number: 11700840
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: July 18, 2023
    Assignee: THE INSTITUTE FOR ETHNOMEDICINE
    Inventors: Kenneth Rodgers, Rachael Dunlop, Paul A. Cox
  • Compositions comprising a metal and L-serine, and uses thereof
    Patent number: 11278512
    Abstract: Presented herein are compositions comprising L-serine, or a precursor, derivative or conjugate thereof, and a non-toxic metal, such as zinc. Compositions disclosed herein can be used for the prevention and treatment of neurodegenerative diseases, or related symptoms thereof.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: March 22, 2022
    Assignee: BRAIN CHEMISTRY LABS
    Inventors: Paul Alan Cox, Sandra Anne Banack, James S. Metcalf, Rachael Dunlop
  • METHODS OF DETECTION AND ANALYSIS OF NUCLEIC ACID IN NEURAL-DERIVED EXOSOMES
    Publication number: 20210164051
    Abstract: Presented herein are methods of identifying a subject who has, or is at risk of developing a motor neuron disease comprising determining a presence or amount of one or more neural-derived micro-RNAs (miRNAs). Also presented herein are method of preventing, treating or delaying the onset of a motor neuron disease.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 3, 2021
    Inventors: Sandra Anne BANACK, Rachael DUNLOP, Paul Alan COX
  • L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS
    Publication number: 20210153483
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Kenneth RODGERS, Rachael DUNLOP, Paul A. COX
  • COMPOSITIONS COMPRISING A METAL AND L-SERINE, AND USES THEREOF
    Publication number: 20210052533
    Abstract: Presented herein are compositions comprising L-serine, or a precursor, derivative or conjugate thereof, and a non-toxic metal, such as zinc. Compositions disclosed herein can be used for the prevention and treatment of neurodegenerative diseases, or related symptoms thereof.
    Type: Application
    Filed: August 21, 2020
    Publication date: February 25, 2021
    Inventors: Paul Alan COX, Sandra Anne BANACK, James S. METCALF, Rachael DUNLOP
  • L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS
    Publication number: 20180027781
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Application
    Filed: October 6, 2017
    Publication date: February 1, 2018
    Applicant: THE INSTITUTE FOR ETHNOMEDICINE
    Inventors: Kenneth Rodgers, Rachael Dunlop, Paul A. Cox